Peripheral leucocyte count variations in rectal cancer treatment

Eur J Surg Oncol. 2009 Jun;35(6):611-6. doi: 10.1016/j.ejso.2008.12.016. Epub 2009 Jan 24.

Abstract

Aim: Mortality after curative surgery for rectal cancer is increased if surgery is not performed within a week of completed short course radiotherapy. A link to the suppression of leucocytes after neoadjuvant radiotherapy has been suggested. This study investigates the effects of radiotherapy on peripheral leucocyte counts, complications and survival.

Method: Patient data variables from a retrospective database (Local and National Swedish Registries) of a total of 926 consecutive patients treated for rectal cancer disease at two surgical units (1993-2004) were analysed for leucocyte counts and mortality. In all 310 patients received radiotherapy. Mean follow-up time was 2.8 years.

Results: There was a marked suppression of leucocytes in the irradiated groups coupled with a reduction in leucocyte response to surgery (p<0.05) compared to non-irradiated patients. Long course radiotherapy resulted in a better postoperative leucocyte response. Irradiated patients with a low post/preoperative leucocyte ratio had higher complication rates. No association between leucocyte response and survival was seen in the irradiated group.

Conclusions: Postoperative leucocytosis is impaired after neoadjuvant radiotherapy, independent of latency period to surgery. Irradiated patients with a suppression of leucocyte response had significantly higher complication rates. The true extent of survival could not be measured in radiotherapy groups due to the short median follow-up period.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Leukocyte Count*
  • Male
  • Middle Aged
  • Neoadjuvant Therapy
  • Rectal Neoplasms / blood*
  • Rectal Neoplasms / mortality
  • Rectal Neoplasms / radiotherapy
  • Rectal Neoplasms / surgery
  • Survival Analysis
  • Young Adult